Live feed16:05:00·43dPRReleasevia QuantisnowSana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPsByQuantisnow·Wall Street's wire, on your screen.SANA· Sana Biotechnology Inc.Health Care
